Amturnide

Active Ingredient(s): Amlodipine + Aliskiren + Hydrochlorothiazide
FDA Approved: * December 21, 2010
Pharm Company: * NOVARTIS PHARMS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Amturnide Overview

The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved in the United States on 21 December 2010.[1][2] References ^ Amturnide approval letter. U.S. Food and Drug Administration (FDA). ^ "Drug Approval Package: Amturnide(amlodipine/aliskiren/hydrochlorothiazide) NDA #200045". U.S. Food and Drug Administration (FDA). 15 August 2011. Retrieved 27 August 2020. Lay summary (PDF)..mw-parser-out...

Read more Amturnide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aliskiren/amlodipine/hydrochlorothiazide

Recent Amturnide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amlodipine + Aliskiren + Hydrochlorothiazide
  • Tablet: 150 + 5 + 12.5mg, 150mg + 5mg + 12.5mg, 300mg + 10mg + 12.5mg, 300mg + 10mg + 25mg, 300mg + 5mg + 12.5mg, 300mg + 5mg + 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Amturnide: (5 results)

Sorted by National Drug Code
  • 0078-0610 Amturnide (Aliskiren Hemifumarate 165.8 mg / Amlodipine Besylate 6.9 mg / Hctz 12.5 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0611 Amturnide (Aliskiren Hemifumarate 331.5 mg / Amlodipine Besylate 6.9 mg / Hctz 12.5 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0612 Amturnide (Aliskiren Hemifumarate 331.5 mg / Amlodipine Besylate 6.9 mg / Hctz 25 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0613 Amturnide (Aliskiren Hemifumarate 331.5 mg / Amlodipine Besylate 13.9 mg / Hctz 12.5 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0614 Amturnide (Aliskiren Hemifumarate 331.5 mg / Amlodipine Besylate 13.9 mg / Hctz 25 mg) Oral Tablet by Novartis Pharmaceuticals Corporation

Drugs with one or more similar ingredients: (91 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA